We are live on
!
Find out more
XT
XTX Topco Portfolio holdings
AUM
$5.75B
1-Year Est. Return
30.56%
This Fund
S&P 500
This Quarter
Est. Return
+0.17%
1 Year Est. Return
+30.56%
3 Year Est. Return
+70.38%
5 Year Est. Return
+43.83%
10 Year Est. Return
–
AUM
$3.81B
AUM Growth
+$1.88B
(+98%)
Cap. Flow
+$1.94B
Cap. Flow
% of AUM
50.99%
Top 10 Holdings %
Top 10 Hldgs %
5.52%
Holding
3,983
New
1,493
Increased
1,108
Reduced
652
Closed
727
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$25.6M |
| 2 |
JPMorgan Chase
JPM
|
+$21.7M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$19.7M |
| 4 |
Kroger
KR
|
+$17.9M |
| 5 |
T-Mobile US
TMUS
|
+$15.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$11.3M |
| 2 |
Thermo Fisher Scientific
TMO
|
+$8.42M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$8.34M |
| 4 |
Cisco
CSCO
|
+$8.02M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$8.01M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.84% |
| 2 | Technology | 16.54% |
| 3 | Industrials | 11.45% |
| 4 | Healthcare | 11.32% |
| 5 | Consumer Discretionary | 9.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AMZE
3126
Amaze Holdings
AMZE
$1.84M
| $14.7K | ﹤0.01% |
+4,841
| New | +$32.6K |
|
|
PXIU
3127
DELISTED
T-REX 2X Long UPXI Daily Target ETF
PXIU
| $14.5K | ﹤0.01% |
+10,838
| New | +$116K |
|
|
NIPG
3128
NIP Group Inc
NIPG
$114M
| $14.5K | ﹤0.01% |
+484
| New | +$20.7K |
|
|
LBGJ
3129
Li Bang International
LBGJ
$101K
| $14.3K | ﹤0.01% |
+221
| New | +$14.1K |
|
|
PTLE
3130
PTL Ltd
PTLE
$62.8M
| $14.2K | ﹤0.01% |
1,770
+931
| +111% | +$12.4K |
|
3131
Pop Culture Group
CPOP
$4.62M
| $14.2K | ﹤0.01% |
+3,374
| New | +$20.2K |
|
|
AKTX
3132
Akari Therapeutics
AKTX
$14.8M
| $14.2K | ﹤0.01% |
+1,225
| New | +$28.5K |
|
|
COOT
3133
Australian Oilseeds Holdings
COOT
$11.2M
| $14.1K | ﹤0.01% |
27,458
-3,012
| -10% | -$3.19K |
|
3134
SciSparc
SPRC
$3.06M
| $14.1K | ﹤0.01% |
+1,148
| New | +$29.2K |
|
3135
Cardlytics
CDLX
$22.3M
| $14K | ﹤0.01% |
1,218
-1,812
| -60% | -$28K |
|
|
CURX
3136
Curanex Pharmaceuticals
CURX
$5.62M
| $14K | ﹤0.01% |
+42,385
| New | +$23.3K |
|
|
INLF
3137
INLIF Ltd
INLF
$366K
| $13.7K | ﹤0.01% |
+9
| New | +$18.9K |
|
3138
Bullfrog AI
BFRG
$10.8M
| $13.6K | ﹤0.01% |
15,430
+2,514
| +19% | +$2.94K |
|
3139
Beyond Air
XAIR
$3.93M
| $13.2K | ﹤0.01% |
+911
| New | +$29.7K |
|
3140
Netcapital
NCPL
$2.97M
| $13.2K | ﹤0.01% |
+20,022
| New | +$32.4K |
|
3141
Millennium Group International
MGIH
$18.3M
| $13.1K | ﹤0.01% |
+10,473
| New | +$17.3K |
|
3142
Expion360
XPON
$3.42M
| $13.1K | ﹤0.01% |
+1,607
| New | +$23.5K |
|
|
SGRP
3143
DELISTED
SPAR Group
SGRP
| $12.9K | ﹤0.01% |
16,358
+3,259
| +25% | +$3.13K |
|
|
SGN
3144
DELISTED
Signing Day Sports
SGN
| $12.8K | ﹤0.01% |
+13,500
| New | +$18.7K |
|
3145
Cyclerion Therapeutics
CYCN
$15.2M
| $12.7K | ﹤0.01% |
+10,027
| New | +$17.9K |
|
3146
Femasys
FEMY
$8.82M
| $12.7K | ﹤0.01% |
1,102
-1,104
| -50% | -$16.7K |
|
|
STAK
3147
STAK Inc
STAK
$42.1M
| $12.7K | ﹤0.01% |
31,798
+8,287
| +35% | +$4.96K |
|
3148
Addentax Group
ATXG
$3.63M
| $12.6K | ﹤0.01% |
2,149
-2,844
| -57% | -$25.6K |
|
|
CDTG
3149
CDT Environmental Technology Investment Holdings
CDTG
$2.87M
| $12.6K | ﹤0.01% |
1,447
+546
| +61% | +$7.11K |
|
|
ALBT
3150
DELISTED
Avalon GloboCare
ALBT
| $12.4K | ﹤0.01% |
+10,371
| New | +$18.4K |
|
Similar funds
HW
AAM
RWM
SAM
PP
VH
TSW
KIM
XTX Topco's Q4 2025 Portfolio in Review
As of Q4 2025, XTX Topco held 3,983 positions worth $3.81B, up 98% from $1.93B the previous quarter. Its ten largest holdings account for 5.5% of the portfolio.
XTX Topco deployed $1.94B of net new capital in Q4 2025, opening 1,493 new positions and adding to 1,108 existing holdings. Its largest new stake was T-Mobile US: 74,738 shares worth $15.2M.
By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 14% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $8.34M trimmed.
- XTX Topco's largest Q4 2025 buy was T-Mobile US: 74,738 shares worth $15.2M.
- XTX Topco added most to Procter & Gamble in Q4 2025, an estimated $25.6M increase.
- XTX Topco's biggest Q4 2025 reduction was Bristol-Myers Squibb, cutting an estimated $8.34M.
- XTX Topco fully exited Johnson & Johnson in Q4 2025, selling an estimated $11.3M.
- XTX Topco's ten largest holdings make up 5.5% of its $3.81B portfolio in Q4 2025.
- XTX Topco opened 1,493 new positions and closed 727 in Q4 2025.
- XTX Topco's portfolio value rose 98% quarter-over-quarter to $3.81B.
Based on XTX Topco's 13F filing for Q4 2025, filed 17 Feb 2026.